semaglutide autoimmune disease and Disease: Safety and Clinical Guidelines What Ozempic, Mounjaro & Zepbound – Ozempic for Autoimmune Disease: UK

Researchers said while the risk is low, the rising use of GLP-1s in patients with and without Type 2 diabetes warrants special attention to medication safety

Genetic Testing and Personalized Weaning Plans Your genetic makeup influences how quickly your body recovers appetite signaling and how vulnerable you are to weight regain after stopping GLP-1 therapy

Li, X., Wang, Y

Impact of ethnicity on progress of glycaemic control in 131 935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register

The same is true for any medication that causes significant weight loss